Linking gene expression patterns to therapeutic groups in breast cancer

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2232-2238

  Martin, Katherine J ^a   Kritzman, Brian M ^a   Price, Laura M ^a   Koh, B Brian ^a   Kwan, Chi Pong ^a   Zhang, Xiaohong ^a   Mackay, Alan ^b   O'Hare, Michael J ^b   Kaelin, Carolyn M ^c   Mutter, George L ^c   Pardee, Arthur B ^a   Sager, Ruth ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLUSTER ANALYSIS; DIAGNOSTIC VALUE; GENE CLUSTER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KERATINS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEINS; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SERPINS; TUMOR CELLS, CULTURED;

EID: 0034655160     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., and Brown, P. O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet., 23: 41-46, 1999.
2. Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. Expression profiling using cDNA microarrays. Nat. Genet., 21: 10-14, 1999.
3. Oh, J. M., Hanash, S. M., and Teichroew, D. Mining protein data from two-dimensional gels: tools for systematic post-planned analyses. Electrophoresis, 20: 766-774, 1999.
4. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Washington DC), 286: 531-537, 1999.
5. Tavassoli, F. A., and Schnitt, S. J. Pathology of the Breast, New York: Elsevier, 1992.
6. Sager, R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA, 94: 952-955, 1997.
7. Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C., Lashkari, D., Shalon, D., Brown, P. O., and Botstein, D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA, 96: 9212-9217, 1999.
8. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
9. Martin, K. J., and Pardee, A. B. Principles of differential display. Methods Enzymol., 303: 234-258, 1999.
10. Clarke, C., Titley, J., Davies, S., and O'Hare, M. J. An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol., 3: 38-46, 1994.
11. Cailleau, R., Olive, M., and Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro (Rockville), 14: 911-915, 1978.
12. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
13. Band, V., Zajchowski, D., Swisshelm, K., Trask, D., Kulesa, V., Cohen, C., Connolly, J., and Sager, R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res., 50: 7351-7357, 1990.
14. Band, V., and Sager, R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
15. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutler, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
16. Martin, K. J., Kwan, C. P., and Sager, R. A direct-sequencing-based strategy for identifying and cloning cDNAs from differential display gels. Methods Mol. Biol., 85: 77-85, 1997.
17. Martin, K. J., Kwan, C. P., O'Hare, M. J., Pardee, A. B., and Sager, R. Identification and verification of differential display cDNAs using gene-specific primers and hybridization arrays. Biotechniques, 24: 1018-1026, 1998.
18. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25: 3389-3402, 1997.
19. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. Molecular Biology of the Cell, New York: Garland Publishing, Inc., 1994.
20. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science (Washington DC), 270: 484-487, 1995.
21. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
22. Soule, H. D., Vazguez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
23. Fisher, B., Osborne, C. K., Margolese, A. G., and Bloomer, W. Neoplasms of the breast. In: J. F. Holland, E. Frei, R. C. Bast, D. W. Kule, D. L. Morton, and R. R. Weichselbaum (eds.), Cancer Medicine, Ed. 4, Vol. 2, pp. 1349-2429. Malvern, PA: Lea & Febiger, 1997.
24. Biswas, D. K., Averboukh, L., Sheng, S., Martin, K., Ewaniuk, D. S., Jawde, T. F., Wang, F., and Pardee, A. B. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol. Med., 4: 454-467, 1998.
25. Loftus, S. K., Chen, Y., Gooden, G., Ryan, J. F., Birznieks, G., Hilliard, M., Baxevanis, A. D., Bittner, M., Meltzer, P., Trent, J., and Pavan, W. Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis. Proc. Natl. Acad. Sci. USA, 96: 9277-9280, 1999.
26. Alon, U., Barkai, N., Notterman, D. A., Gish, K., Ybarra, S., Mack, D., and Levine, A. J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl. Acad. Sci. USA, 96: 6745-6750, 1999.
27. Spencer, V. A., Courts, A. S., Samuel, S. K., Murphy, L. C., and Davie, J. R. Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J. Biol. Chem., 273: 29093-29097, 1998.
28. Massot, O., Baskevitch, P. P., Capony, F., Garcia, M., and Rochefort, H. Estradiol increases the production of α 1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines. Mol. Cell. Endocrinol., 42: 207-214, 1985.
29. Vik, D. P., Amiguet, P., Moffat, G. J., Fey, M., Amiguet-Barras, F., Wetsel, R. A., and Tack, B. F. Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry, 30: 1080-1085, 1991.
30. Porter, W., Wang, F., Wang, W., Duan, R., and Safe, S. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol. Endocrinol., 10: 1371-1378, 1996.
31. Yang, G. P., Ross, D. T., Kuang, W. W., Brown, P. O., and Weigel, R. J. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res., 27: 1517-1523, 1999.
32. Gudas, J. M., Nguyen, H., Klein, R. C., Katayose, D., Seth, P., and Cowan, K. H. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res., 1: 71-80, 1995.
33. Berns, E. M., Klijn, J. G., van Putlen, W. L., de Witte, H. H., Look, M. P., Meijer-van Gelder, M. E., Willman, K., Portengen, H., Benraad, T. J., and Foekens, J. A. p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. J. Clin. Oncol., 16: 121-127, 1998.
34. Yu, J., Caragine, T., Chen, S., Morgan, B. P., Frey, A. B., and Tomlinson, S. Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59. Clin. Exp. Immunol., 115: 13-18, 1999.
35. Fan, J. D., Wagner, B. L., and McDonnell, D. P. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol. Endocrinol., 10: 1605-1616, 1996. (Published erratum appears in Mol. Endocrinol., 11: 341).
36. Osborne, C. K. Steroid hormone receptors in breast cancer management. Breast Cancer Res. Treat., 51: 227-238, 1998.
37. Zou, Z., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Washington DC), 263: 526-529, 1994.
38. Zhang, M., Zou, Z., Maass, N., and Sager, R. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res., 55: 2537-2541, 1995.
39. Baum, M. Tamoxifen - the treatment of choice. Why look for alternatives? Br. J. Cancer, 78: 1-4, 1998.
40. Yano, M., Naito, Z., Tanaka, S., and Asano, G. Expression and roles of heat shock proteins in human breast cancer. Jpn. J. Cancer Res., 87: 908-915, 1996.
41. Conroy, S. E., Gibson, S. L., Brunstrom, G., Isenberg, D., Luqmani, Y., and Latchman, D. S. Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients. Lancet, 345: 126, 1995.
42. Knoblauch, R., and Garabedian, M. J. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol. Cell. Biol., 19: 3748-3759, 1999.
43. Taylor-Papadimitriou, J., Stampfer, M., Bartek, J., Lewis, A., Boshell, M., Lane, E. B., and Leigh, I. M. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci., 94: 403-413, 1989.
44. Guelstein, V. I., Tchypysheva, T. A., Ermilova, V. D., and Ljubimov, A. V. Myoepithelial and basement membrane antigens in benign and malignant breast tumors. Int. J. Cancer, 53: 269-277, 1993.
45. Gusterson, B. A., Warburton, M. J., Mitchell, D., Ellison, M., Neville, A. M., and Rudland, P. S. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res., 42: 4763-4770, 1982.
46. Bankfalvi, A., Terpe, H. J., Breukelmann, D., Bier, B., Rempe, D., Pschadka, G., Krech, R., and Bocker, W. Gains and losses of CD44 expression during breast carcinogenesis and tumor progression. Histopathology, 33: 107-116, 1998.
47. Sternlicht, M. D., and Barsky, S. H. The myoepithelial defense: a host defense against cancer. Med. Hypotheses, 48: 37-46, 1997.